Sign In
Buy CERT
$8.10
+0.320 (+4.11%)
At Close: Jul 31, 2026
Best Momentum Stocks to Buy for March 15th
11:28am, Wednesday, 15'th Mar 2023
CERT, BWMX and NUE made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on March 15, 2023.
New Strong Buy Stocks for March 15th
08:27am, Wednesday, 15'th Mar 2023
TRIN, CERT, WPP, NUE and BHR have been added to the Zacks Rank #1 (Strong Buy) List on March 15, 2023.
Can Certara, Inc. (CERT) Run Higher on Rising Earnings Estimates?
01:43pm, Thursday, 09'th Mar 2023
Certara, Inc. (CERT) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Certara, Inc. (CERT) Tops Q4 Earnings and Revenue Estimates
07:34pm, Wednesday, 01'st Mar 2023
Certara, Inc. (CERT) delivered earnings and revenue surprises of 14.29% and 4.34%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Certara to Participate in the Barclays Global Healthcare Conference
04:30pm, Monday, 27'th Feb 2023
PRINCETON, N.J., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that Company management will participate in the Barclays Global Healt
Certara to Report Fourth Quarter and Full Year 2022 Financial Results on March 1st, 2023
04:30pm, Wednesday, 01'st Feb 2023
PRINCETON, N.J., Feb. 01, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the fourth quarter and ful
CERT vs. PBYI: Which Stock Should Value Investors Buy Now?
12:48pm, Monday, 09'th Jan 2023
CERT vs. PBYI: Which Stock Is the Better Value Option?
Why Certara Is A Buy For 2023
07:57am, Tuesday, 06'th Dec 2022
Unlike Schrodinger, Certara posted a profit in the last quarter. Business momentum is accelerating as backlog grows.
Why Certara's Shares Rose 37.7% This Week
04:28pm, Friday, 11'th Nov 2022
The company, which helps other companies in their drug development, reported strong third-quarter numbers.
Certara, Inc. (CERT) Q3 Earnings Miss Estimates
08:19pm, Monday, 07'th Nov 2022
Certara, Inc. (CERT) delivered earnings and revenue surprises of -9.09% and 2.84%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Certara Inc. (CERT) Q3 2022 Earnings Call Transcript
07:49pm, Monday, 07'th Nov 2022
Certara Inc. (NASDAQ:CERT ) Q3 2022 Results Conference Call November 7, 2022 5:00 PM ET Company Participants David Deuchler - IR William Feehery - CEO Andrew Schemick - CFO Conference Call Participant
Certara to Participate in Upcoming Investor Conferences
05:00pm, Wednesday, 02'nd Nov 2022
PRINCETON, N.J., Nov. 02, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that Company management will participate in the following investor co
Certara to Report Third Quarter 2022 Financial Results on November 7th, 2022
07:45am, Thursday, 13'th Oct 2022
PRINCETON, N.J., Oct. 13, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the third quarter of 2022
Certara to Participate in Upcoming Investor Conferences
08:00am, Wednesday, 31'st Aug 2022
PRINCETON, N.J., Aug. 31, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that Company management will participate in the following investor co
Here's Why Certara Stock Is Falling Friday
09:45am, Friday, 12'th Aug 2022
Certara Inc (NASDAQ: CERT) shares are trading lower by 15.40% to $17.08 Friday morning after the company announced a secondary offering of 7 million shares of common stock. What Else?
